RU2036901C1 - Способ получения диароматических соединений - Google Patents

Способ получения диароматических соединений Download PDF

Info

Publication number
RU2036901C1
RU2036901C1 SU894742525A SU4742525A RU2036901C1 RU 2036901 C1 RU2036901 C1 RU 2036901C1 SU 894742525 A SU894742525 A SU 894742525A SU 4742525 A SU4742525 A SU 4742525A RU 2036901 C1 RU2036901 C1 RU 2036901C1
Authority
RU
Russia
Prior art keywords
phenyl
compound
ethyl
general formula
alkyl
Prior art date
Application number
SU894742525A
Other languages
English (en)
Russian (ru)
Inventor
Пол Джексон Вилльям
Джон Харри Клифферд
Джеймс Эрроусмит Ричард
Гордон Дэнн Джон
Джулиан О'Коннор Кевин
Фредерик Джеффри Бут Роберт
Original Assignee
Дзе Веллкам Фаундейшн Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Веллкам Фаундейшн Лимитед filed Critical Дзе Веллкам Фаундейшн Лимитед
Application granted granted Critical
Publication of RU2036901C1 publication Critical patent/RU2036901C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Polarising Elements (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
SU894742525A 1988-11-21 1989-11-20 Способ получения диароматических соединений RU2036901C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8827152.3 1988-11-21
GB888827152A GB8827152D0 (en) 1988-11-21 1988-11-21 Anti-atherosclerotic diaryl compounds

Publications (1)

Publication Number Publication Date
RU2036901C1 true RU2036901C1 (ru) 1995-06-09

Family

ID=10647180

Family Applications (1)

Application Number Title Priority Date Filing Date
SU894742525A RU2036901C1 (ru) 1988-11-21 1989-11-20 Способ получения диароматических соединений

Country Status (27)

Country Link
EP (2) EP0450660B1 (enExample)
JP (1) JPH02188568A (enExample)
KR (1) KR900007790A (enExample)
AT (2) ATE78812T1 (enExample)
AU (1) AU638950B2 (enExample)
CA (1) CA2003395A1 (enExample)
CZ (1) CZ277693B6 (enExample)
DD (1) DD289263A5 (enExample)
DE (2) DE68902301T2 (enExample)
DK (1) DK581889A (enExample)
ES (2) ES2052028T3 (enExample)
FI (1) FI895520A7 (enExample)
GB (1) GB8827152D0 (enExample)
GR (1) GR3006091T3 (enExample)
HU (1) HU205342B (enExample)
IE (2) IE940341L (enExample)
IL (1) IL92358A (enExample)
LT (1) LTIP418A (enExample)
MX (1) MX9203417A (enExample)
MY (1) MY106247A (enExample)
NO (1) NO172233C (enExample)
NZ (1) NZ231448A (enExample)
PL (1) PL162010B1 (enExample)
PT (2) PT92354A (enExample)
RU (1) RU2036901C1 (enExample)
TW (1) TW213445B (enExample)
ZA (1) ZA898842B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216536C2 (ru) * 1997-12-19 2003-11-20 Словакофарма А.С. 1,3-дизамещенные мочевины в качестве ингибиторов холестерол-ацилтрансферазы и способ их получения
RU2247109C2 (ru) * 1997-12-22 2005-02-27 Байер Копэрейшн Симметричные и несимметричные производные дифенилмочевины (варианты), фармацевтическая композиция, способ подавления роста опухолевых клеток, опосредованного киназой raf

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
GB9020841D0 (en) * 1990-09-25 1990-11-07 Wellcome Found Anti-atherosclerotic aryl compounds
GB9027023D0 (en) * 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Disubstituted ureas and thioureas their preparation and pharmaceutical compositions containing them
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
CA2123728A1 (en) * 1993-05-21 1994-11-22 Noriyoshi Sueda Urea derivatives and their use as acat inhibitors
US5776951A (en) * 1993-06-30 1998-07-07 Glaxo Wellcome Inc. Anti-atherosclerotic diaryl compounds
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
CA2200981A1 (en) * 1994-10-04 1996-04-11 Hisashi Takasugi Urea derivatives and their use as acat-inhibitors
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
US5866609A (en) * 1996-08-09 1999-02-02 Ss Pharmaceutical Co., Ltd. Substituted vinylurea derivatives and medicine containing the same
FR2946342B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946346B1 (fr) 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946340B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946345B1 (fr) 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
CA1138451A (en) * 1979-04-03 1982-12-28 Ikuo Ueda 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
US4269829A (en) * 1979-06-18 1981-05-26 Rohm And Haas Company Method and composition for treating helminths containing O,O-dialkyl-N-(substituted phenyl)aminothiocarbonyl phosphoramidates
US4387106A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Method of treating atherosclerosis with di(aralkyl)ureas and di(aralkyl)thioureas
JPS60500176A (ja) * 1982-12-30 1985-02-07 ビ−チヤム　グル−プ　ピ−エルシ− 四環式化合物
US4603145A (en) * 1983-05-06 1986-07-29 American Cyanamid Company Antiatherosclerotic diphenyl alkanamides
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
JPH0193569A (ja) * 1987-07-02 1989-04-12 Warner Lambert Co アシル‐ＣｏＡ：コレステロールアシルトランスフエラーゼのＮ‐〔（２，６‐ジ置換）フエニル〕尿素およびカルバメート阻害剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chem. Ber., 105, 1634, 1972. *
Chem. Ber., 96, 765, 1963. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216536C2 (ru) * 1997-12-19 2003-11-20 Словакофарма А.С. 1,3-дизамещенные мочевины в качестве ингибиторов холестерол-ацилтрансферазы и способ их получения
RU2247109C2 (ru) * 1997-12-22 2005-02-27 Байер Копэрейшн Симметричные и несимметричные производные дифенилмочевины (варианты), фармацевтическая композиция, способ подавления роста опухолевых клеток, опосредованного киназой raf
RU2247109C9 (ru) * 1997-12-22 2005-06-20 Байер Копэрейшн Симметричные и несимметричные производные дифенилмочевины (варианты), фармацевтическая композиция, способ подавления роста опухолевых клеток, опосредованного киназой raf

Also Published As

Publication number Publication date
AU638950B2 (en) 1993-07-15
FI895520A7 (fi) 1990-05-22
FI895520A0 (fi) 1989-11-20
EP0450660B1 (en) 1994-03-09
ATE78812T1 (de) 1992-08-15
NO894616D0 (no) 1989-11-20
DD289263A5 (de) 1991-04-25
ZA898842B (en) 1991-07-31
NZ231448A (en) 1992-03-26
ES2062610T3 (es) 1994-12-16
IE65411B1 (en) 1995-10-18
IE893700L (en) 1990-05-21
KR900007790A (ko) 1990-06-02
NO894616L (no) 1990-05-22
GR3006091T3 (enExample) 1993-06-21
HU205342B (en) 1992-04-28
PT101725B (pt) 1997-08-29
ES2052028T3 (es) 1994-07-01
EP0370740A1 (en) 1990-05-30
ATE102604T1 (de) 1994-03-15
DE68913762T2 (de) 1994-06-23
DE68902301D1 (de) 1992-09-03
EP0450660A1 (en) 1991-10-09
NO172233B (no) 1993-03-15
DK581889A (da) 1990-05-22
EP0370740B1 (en) 1992-07-29
JPH02188568A (ja) 1990-07-24
DE68902301T2 (de) 1993-02-25
IL92358A (en) 1994-06-24
DE68913762D1 (de) 1994-04-14
DK581889D0 (da) 1989-11-20
PT92354A (pt) 1990-05-31
GB8827152D0 (en) 1988-12-29
PL162010B1 (pl) 1993-08-31
AU4536389A (en) 1990-05-24
CZ277693B6 (en) 1993-03-17
NO172233C (no) 1993-06-23
LTIP418A (en) 1994-09-25
IE940341L (en) 1990-05-21
IL92358A0 (en) 1990-07-26
CS655889A3 (en) 1992-11-18
CA2003395A1 (en) 1990-05-21
MX9203417A (es) 1992-07-01
HUT52040A (en) 1990-06-28
TW213445B (enExample) 1993-09-21
PT101725A (pt) 1996-01-31
MY106247A (en) 1995-04-29

Similar Documents

Publication Publication Date Title
RU2036901C1 (ru) Способ получения диароматических соединений
US5015644A (en) Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
US5510379A (en) Sulfonate ACAT inhibitors
EP1042278B1 (en) 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
RU2318802C2 (ru) Производные амида коричной кислоты
EP1753721B1 (en) Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
HRP20090270A2 (hr) Derivati dioksan-2-alkil karbamata, metoda njihove pripreme i primjena istih u terapeutske svrhe
KR100806603B1 (ko) 아미노알킬아미드 치환된 사이클로헥실 유도체
US5395853A (en) Anti-atherosclerotic diaryl compounds
US5288757A (en) Aminosulfonyl urea ACAT inhibitors and a method of lowering blood cholesterol levels therewith
EP0297610A1 (en) N-[(2,6-disubstituted)phenyl]-urea and carbamate inhibitors of acyl-CoA:cholesterol acyl-transferase
EP0556308B1 (en) Oxysulfonyl urea acat inhibitors
US5733931A (en) Cyclohexanediurea derivative and process for its production
US5491170A (en) β-carboxy sulfonamide ACAT inhibitors
US5202351A (en) 1-phenylalkyl-3-phenylurea derivative
US7439394B2 (en) Cyclohexyl-1,4-diamine compounds
US5142094A (en) Aryl substituted carbamate derivatives which are acat inhibitors
US5384328A (en) Oxysulfonyl carbamates
KR940011151B1 (ko) 시클로알킬 우레아 화합물
AU654688B2 (en) Oxysulfonyl carbamates
US7786328B2 (en) Cyclohexyl-1,4-diamine compounds
CA2566210A1 (en) Oxo-substituted cyclohexyl-1,4-diamine derivatives
ES2319213T3 (es) Inhibidores de mao-b.
Nakao et al. Novel hydroxyphenylurea dual inhibitor against acyl-CoA: cholesterol acyltransferase (ACAT) and low density lipoprotein (LDL) oxidation as antiatherosclerotic agent
US5173510A (en) Simplified thioester and isostere analogs of oleoyl coenzyme A as hypocholesterolemic agents